DEC 16, 2019 1:17 PM PST

Drug Targets Against The Nipah Virus

WRITTEN BY: Nouran Amin

The Nipah virus, first identified in 1998 and is transmitted from pigs and bats, has resulted in a high mortality rate killing more than half of all infected individuals in Bangladesh and India. Although, there has not been more than 150 fatalities from the virus, it is still a deadly threat that may lead to a pandemic. To counteract that issue, researchers have examined the molecular structure of the virus to come up with 150 possible drug targets.

Learn more about the Nipah virus:

The drug targets identified were possible inhibitors of the virus that block its detrimental effects. In the study, researchers from the Indian Institute of Science Education first modeled in 3D nine Nipah virus proteins before designing inhibitory molecules that block the activity of the protein. They then tested the efficacy of these inhibitors on 15 different viral strains.

Using computational analysis, they identified 4 putative peptides inhibitor therapeutics against the Nipah virus protein products and an additional 146 small molecule inhibitors. Overall, thirteen compounds were believed to the most promising based on characteristics such as strength, stability, and effectiveness against variable Nipah viral strains.

"We conclude that it is highly likely that the proposed inhibitors would be potent against all strains of the virus Nipah and other related zoonotic viruses that pose a serious epidemic threat," the researchers say. "Computational approaches can help identify and design inhibitors that could be rapidly tested or even deployed."

Findings were published in the journal, PLOS Neglected Tropical Diseases.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
AUG 22, 2020
Drug Discovery & Development
Could a Drug for Bipolar Disorder Treat COVID-19?
AUG 22, 2020
Could a Drug for Bipolar Disorder Treat COVID-19?
Researchers have found that a drug currently used to treat bipolar disorder and hearing loss may also treat COVID-19 tha ...
AUG 25, 2020
Cannabis Sciences
Synthetic Cannabinoid Drug to Enter Human Trials
AUG 25, 2020
Synthetic Cannabinoid Drug to Enter Human Trials
In recent months, interest has been growing in the potential for cannabinoids- the compounds found in cannabis- to treat ...
AUG 31, 2020
Cancer
Targeting Your Inner Hedgehog to Fight Chemoresistance in Colorectal Cancer
AUG 31, 2020
Targeting Your Inner Hedgehog to Fight Chemoresistance in Colorectal Cancer
Chemoresistance is a serious problem for many cancer therapies. Solutions to this problem are harder to come by than the ...
SEP 03, 2020
Drug Discovery & Development
Combination of Cholesterol Lowering Drugs Effective in Reducing Heart Disease
SEP 03, 2020
Combination of Cholesterol Lowering Drugs Effective in Reducing Heart Disease
A recent European study found that individuals taking a combination of lipid-lowering therapeutics may reduce the risk o ...
SEP 10, 2020
Drug Discovery & Development
Improving Chemotherapeutic Delivery
SEP 10, 2020
Improving Chemotherapeutic Delivery
One particular form of stubborn cancer, known as hepatocellular carcinoma, has been challenging to treat and as a result ...
OCT 23, 2020
Drug Discovery & Development
FDA Gives Full Approval to Remdesivir to Treat COVID-19
OCT 23, 2020
FDA Gives Full Approval to Remdesivir to Treat COVID-19
The US Food and Drug Administration (FDA) has approved antiviral drug Remdesivir, sold under the name ‘Velkury&rsq ...
Loading Comments...